To print this article, all you need is to be registered or login on Mondaq.com.
Each month our health team will update you on key recent
developments, and look ahead to what's coming up in your
sector.
This month, you'll hear from Esther in health commercial,
Louise in health advisory, and Monia in health litigation.
We hope you find this of interest. If you have any comments,
please do let us know.
Originally Published By Hill Dickinson, November
2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
In Part 2 of our series of consecutive articles on the reformed regulatory framework under the EU Medical Device Regulation 2017/745 ("MDR"), which will soon govern medical devices software...
Nearly one year after its introduction to the House of Commons, the Medicines and Medical Devices Bill 2019‑2021 (the Bill) was granted Royal Assent on 11 February 2021, becoming law...
Two companies have applied to the Food Standards Agency ("FSA") for approval to market their novel food products in the EU under the Novel Food Regulation (EC) 258/97.
On 23 October 2003, the European Court of First Instance (the "CFI") held that an exclusivity clause restricting ice-cream retailers' use of freezers supplied by Van den Bergh Foods in Ireland infringed EC competition law. Van Den Bergh Foods, formerly HB Ice Cream Ltd ("HB") is a wholly owned subsidiary of Unilever plc. It is the main manufacturer of impulse ice-cream products (single-wrapped ice-creams for immediate consumption) in Ireland. For a number of years it has supplied retailers w
